Skip to content

Clinical trials

Terminated Phase 2 Liver Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2 Status: Terminated Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20071
20091
20121
20151
20162
20181
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Emory University1
Gachon University Gil Medical Center1
Genfit1
Hospital Clinic of Barcelona1
Mayo Clinic1
Merck Sharp & Dohme LLC1
Mirum Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases14
Fibrosis3
Non-alcoholic Fatty Liver Disease3
Carcinoma, Hepatocellular2
Digestive System Neoplasms2
Hepatitis2
Liver Neoplasms2
Neoplasms by Site2
Acute-On-Chronic Liver Failure1
Adenocarcinoma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.